Scalable solution for delivery of diabetes self-management education in Thailand (DSME-T): a cluster randomised trial study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 10 2020
Historique:
entrez: 6 10 2020
pubmed: 7 10 2020
medline: 15 5 2021
Statut: epublish

Résumé

Type 2 diabetes mellitus is among the foremost health challenges facing policy makers in Thailand as its prevalence has more than tripled over the last two decades, accounting for considerable death, disability and healthcare expenditure. Diabetes self-management education (DSME) programmes show promise in improving diabetes outcomes, but this is not routinely used in Thailand. This study aims to test a culturally tailored DSME model in Thailand, using a three-arm cluster randomised controlled trial comparing a nurse-led model, a peer-assisted model and standard care. We will test which model is effective and cost effective to improve cardiovascular risk and control of blood glucose among people with diabetes. 21 primary care units in northern Thailand will be randomised to one of three interventions, enrolling a total of 693 patients. The primary care units will be randomised (1:1:1) to participate in a culturally-tailored DSME intervention for 12 months. The three-arm trial design will compare effectiveness of nurse-led, peer-assisted (Thai village health volunteers) and standard care. The primary trial outcomes are changes in haemoglobin A1c and cardiovascular risk score. A process evaluation and cost effectiveness evaluation will be conducted to produce policy relevant guidance for the Thai Ministry of Public Health. The planned trial period will start in January 2020 and finish October 2021. Ethical approval has been obtained from Thailand and the UK. We will share our study data with other researchers, advertising via our publications and web presence. In particular, we are committed to sharing our findings and data with academic audiences in Thailand and other low-income and middle-income countries. NCT03938233.

Identifiants

pubmed: 33020090
pii: bmjopen-2020-036963
doi: 10.1136/bmjopen-2020-036963
pmc: PMC7537447
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0

Banques de données

ClinicalTrials.gov
['NCT03938233']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036963

Subventions

Organisme : Medical Research Council
ID : MR/R020876/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Diabetes Care. 2010 Apr;33(4):745-7
pubmed: 20103547
Qual Life Res. 2013 Aug;22(6):1499-506
pubmed: 22926727
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Clin Diabetes Endocrinol. 2017 May 25;3:4
pubmed: 28702258
J Med Assoc Thai. 2011 Nov;94(11):1304-13
pubmed: 22256469
BMJ. 2012 Apr 26;344:e2333
pubmed: 22539172
BMC Fam Pract. 2020 Aug 21;21(1):173
pubmed: 32825811
Biopsychosoc Med. 2010 Jun 12;4:6
pubmed: 20540784
J Behav Med. 2014 Apr;37(2):218-33
pubmed: 23188480
Global Health. 2013 Mar 14;9:11
pubmed: 23497447
Diabet Med. 2006 May;23(5):544-56
pubmed: 16681564
Patient Educ Couns. 2016 Jun;99(6):926-43
pubmed: 26658704
Fam Pract. 2002 Jun;19(3):257-63
pubmed: 11978716
Health Aff (Millwood). 2012 Jan;31(1):130-9
pubmed: 22232103
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
N Engl J Med. 2003 Jan 30;348(5):383-93
pubmed: 12556541
BMJ Open. 2017 Jun 4;7(5):e013805
pubmed: 28583913
BMJ Open. 2015 Jul 15;5(7):e007635
pubmed: 26179646
Lancet. 1998 Sep 12;352(9131):854-65
pubmed: 9742977
Diabetes Educ. 2012 Sep-Oct;38(5):619-29
pubmed: 22996411
Diabetes Care. 2006 Aug;29(8):1872-7
pubmed: 16873795
Ann Intern Med. 2015 Dec 1;163(11):848-60
pubmed: 26414227
Diabet Med. 2012 Nov;29(11):1361-77
pubmed: 22804713
Int J Endocrinol. 2017;2017:2503156
pubmed: 29201051
J Am Coll Cardiol. 2016 Feb 2;67(4):456-458
pubmed: 26821636
Nurs Health Sci. 2007 Jun;9(2):135-41
pubmed: 17470188

Auteurs

Chaisiri Angkurawaranon (C)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand chaisiri.a@cmu.ac.th.

Iliatha Papachristou Nadal (I)

Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health,London School of Hygiene and Tropical Medicine, London, UK.

Poppy Alice Carson Mallinson (PAC)

Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health,London School of Hygiene and Tropical Medicine, London, UK.

Kanokporn Pinyopornpanish (K)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Orawan Quansri (O)

ASEAN Institute for Health Development, Mahidol University, Salaya, Thailand.

Kittipan Rerkasem (K)

Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.

Supattra Srivanichakorn (S)

Royal Thai Government Ministry of Public Health, Bangkok, Thailand.

Win Techakehakij (W)

Lampang Hospital, Lampang, Thailand.

Nutchanath Wichit (N)

Surat Thani Rajabhat University, Surat Thani, Thailand.

Chanapat Pateekhum (C)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Ahmar H Hashmi (AH)

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Kara Hanson (K)

Department of Global Health and Development, Faculty of Public Health of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Kamlesh Khunti (K)

Department of Health Sciences, University of Leicester, Leicester, UK.

Sanjay Kinra (S)

Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health,London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH